Long Yu
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Aquatic Science top 1%
- Seaweed-derived Bioactive Compounds
Papers in
- Hepatology 26
- Hepatocellular Carcinoma Treatment and Prognosis 25
- Oncology 29
- Cancer Cells and Metastasis 9
- Co-authors
- Peter N. Devreotes (12 shared papers)Zhan Xiao (1 shared paper)Yihong Yao (1 shared paper)Yaoguang Chang (9 shared papers)Changhu Xue (9 shared papers)Xiaoqi Xu (7 shared papers)Carole A. Parent (2 shared papers)Yuliang Ran (20 shared papers)
- Journals
- Carbohydrate Polymers (8 papers)Journal of Cancer (7 papers)Food Chemistry (5 papers)Frontiers in Immunology (5 papers)Cancer Medicine (4 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Long Yu
175 papers receiving 5.3k citations
Long Yu's Hit Papers
Peers
Comparison fields: 5 of 138
- Cancer Research 707
- Aquatic Science 351
- Oncology 720
- Hepatology 244
- Molecular Biology 1.7k
Countries citing papers authored by Long Yu
This map shows the geographic impact of Long Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long Yu more than expected).
Fields of papers citing papers by Long Yu
This network shows the impact of papers produced by Long Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long Yu. The network helps show where Long Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Long Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 431 | |
| 2 | Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer Hit paper breakdown → | 2023 | 347 |
| 3 | 2000 | 250 | |
| 4 | 2012 | 193 | |
| 5 | 2009 | 172 | |
| 6 | 2004 | 154 | |
| 7 | Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: a research review Hit paper breakdown → | 2023 | 150 |
| 8 | 2010 | 112 | |
| 9 | 2017 | 111 | |
| 10 | 2013 | 89 | |
| 11 | 2020 | 89 | |
| 12 | 2015 | 87 | |
| 13 | 2014 | 84 | |
| 14 | 2022 | 84 | |
| 15 | 2013 | 79 | |
| 16 | 2009 | 76 | |
| 17 | 2015 | 69 | |
| 18 | 2014 | 63 | |
| 19 | 2016 | 61 | |
| 20 | 2017 | 61 |
About Long Yu
Long Yu is a scholar working on Hepatology, Oncology, Cancer Research, Molecular Biology and Aquatic Science, having authored 183 papers that have together received 5.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Hepatitis B Virus Studies (13 papers), Genetic Associations and Epidemiology (13 papers), Radiopharmaceutical Chemistry and Applications (10 papers), Cancer Cells and Metastasis (9 papers), Seaweed-derived Bioactive Compounds (9 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Mechanisms of cancer metastasis (6 papers). The work is most often cited by research in Cancer Research (707 citations), Aquatic Science (351 citations), Oncology (720 citations), Hepatology (244 citations) and Molecular Biology (1.7k citations). Long Yu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Peter N. Devreotes, Zhan Xiao, Yihong Yao, Yaoguang Chang, Changhu Xue, Xiaoqi Xu, Carole A. Parent, Yuliang Ran, Vincent Bulone and Yanchao Wang. Their work appears in journals such as Carbohydrate Polymers, Journal of Cancer, Food Chemistry, Frontiers in Immunology and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.